Schistosomiasis, also known as bilharzia or snail fever, is a parasitic disease caused by blood flukes (trematode worms) of the genus Schistosoma. There are several species of schistosomes that infect humans, the most important being Schistosoma haematobium, Schistosoma mansoni, and Schistosoma japonicum. 

**Global Prevalence and Transmission:**
Schistosomiasis is a disease of poverty that remains a significant global health concern, particularly in tropical and subtropical regions. According to the World Health Organization (WHO), over 230 million people required preventative treatment for schistosomiasis in 2019, and it affects approximately 120 million people worldwide, with millions more at risk. 

The disease is endemic in many parts of Africa, but it also exists in some areas of the Middle East, South America, the Caribbean, and Southeast Asia. The lifecycle of the parasites includes freshwater snails as intermediate hosts. Human infection occurs when people come into contact with contaminated freshwater where the snails release larval forms of the parasite. The larvae can penetrate human skin and develop into adult worms, which live in the blood vessels, where they produce eggs. Some of the eggs are expelled in feces or urine, which can then contaminate freshwater bodies and continue the cycle if they reach suitable snail hosts.

**Historical Context and Discovery:**
The disease has been known since ancient times, with descriptions that resemble schistosomiasis found in Egyptian medical papyri dating back to around 2000 BCE. The connection between the disease and the schistosome worms, however, was not made until much later. The discovery of the organism responsible for schistosomiasis is attributed to Theodor Bilharz, a German pathologist, who identified the worms in 1851 during autopsy examinations in Egypt.

**Risk Factors:**
Several factors contribute to the transmission and risk of schistosomiasis:
- Contact with contaminated water, typically during activities such as swimming, bathing, fishing, laundry, or agricultural work.
- Poor sanitation infrastructure, which facilitates contamination of water bodies with human waste.
- Proximity to freshwater bodies that host the snail intermediate.
- Lack of access to safe drinking water and health education.

**Impact on Different Regions and Populations:**
The impact of schistosomiasis varies significantly from one region to another and across different demographics. In endemic regions:
- Prevalence can be exceptionally high, particularly in rural areas and amongst populations that rely on freshwater from rivers and lakes for daily activities.
- School-aged children are often the most affected due to their frequent contact with contaminated water.
- Chronic infection can result in anemia, malnutrition, learning difficulties, and severe organ damage, especially of the bladder, kidneys, liver, and intestines.
- Schistosomiasis significantly contributes to economic and social burden, hampering development and perpetuating cycles of poverty.

**Key Statistics and Variations in Prevalence:**
- In Africa, which bears the brunt of the global schistosomiasis burden, prevalence rates can exceed 50% in some communities.
- Different species have varied geographic distributions, with S. haematobium being predominant in Africa and the Middle East, S. mansoni in Africa, parts of South America, and the Caribbean, and S. japonicum in parts of China and Southeast Asia.
- Morbidity due to schistosomiasis is estimated at 1.9 million disability-adjusted life years (DALYs) lost, with a greater burden in sub-Saharan Africa.

**Control and Prevention Efforts:**
The primary approach to controlling schistosomiasis has been through mass drug administration (MDA) with praziquantel, which effectively kills adult worms. Other strategies include improving sanitation, providing access to safe water, snail control, health education, and developing strong surveillance systems to monitor and respond to the disease. Limited progress towards a vaccine exists, with various candidate vaccines in different stages of research and development.

Schistosomiasis encapsulates the challenges of a disease that is closely tied to environmental conditions, socioeconomic status, and public health infrastructure. Sustained integrated efforts are required to not only treat the disease but also to prevent its spread and ultimately aim for its elimination in endemic regions.